Oxford Biomedica annual capital expenditures (capex)
2020
2021
2022
2023
2024
2025
Oxford Biomedica Capital Expenditures (CapEx) Growth & History (OXB)
Oxford Biomedica's capital expenditures (capex) was £4.8M for fiscal 2025.
View full Oxford Biomedica company overviewOxford Biomedica annual capital expenditures (capex) history
| Fiscal year | Period ended | Capital expenditures (CapEx) | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | £4.8M | −£2.7M | −36.49% |
| 2024 | 2024-12-31 | £7.5M | −£2.3M | −23.76% |
| 2023 | 2023-12-31 | £9.8M | −£6.5M | −39.67% |
| 2022 | 2022-12-31 | £16.3M | £6.8M | +72.24% |
| 2021 | 2021-12-31 | £9.5M | −£3.9M | −29.17% |
| 2020 | 2020-12-31 | £13.4M | — | — |
Oxford Biomedica capital expenditures (capex) trends
Over the last five fiscal years, Oxford Biomedica's capital expenditures (capex) decreased from £13.4M to £4.8M, a change of −£8.6M.
About the metric
What capital expenditures (CapEx) mean
Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.
Calculation and source
reported capital expenditures
TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company official filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Oxford Biomedica source filings ↗